Art. 29 Directive (EU) 2011/83

Reporting requirements

In forcesince 27 Sep 2026cited 4×
1.

Where a Member State makes use of any of the regulatory choices referred to in Article 3(4), Article 6(7), Article 6(8), Article 7(4), Article 8(6), Article 9(1a) and (3), Article 16, second and third paragraphs, Article 16a(2) and (9), Article 16b(7) and Article 16e, it shall inform the Commission thereof by 19 December 2025, as well as of any subsequent changes.

2.

The Commission shall ensure that the information referred to in paragraph 1 is easily accessible to consumers and traders, inter alia, on a dedicated website.

3.

The Commission shall forward the information referred to in paragraph 1 to the other Member States and the European Parliament. The Commission shall consult stakeholders on that information.

  • Directive (EU) 2019/2161Lawamends

  • Directive (EU) 2023/2673Lawamends

  • Arrêt du Tribunal (cinquième chambre) du 11 décembre 2014. PP Nature-Balance Lizenz GmbH contre Commission européenne.Decision

    … 2010 auf, die Zulassungen für das Tolperisonhydrochlorid enthaltende Humanarzneimittel „Myderison“ im Rahmen des Art. 29 der Richtlinie 2011/83 zu widerrufen oder zu verweigern.

    11 Dec 2014 · 62013TJ0189

  • Judgment of the Court (Sixth Chamber) of 3 February 2021. Stichting Waternet v MG.Decision

    Stichting Waternet accordingly brought an appeal on a point of law before the referring court, the Hoge Raad der Nederlanden (Supreme Court of the Netherlands). That court is uncertain whether, in view of the current practice in the …

    3 Feb 2021 · 62019CJ0922